Such a manifestation finds its roots in the heightened activity of TRAF2/IL-6, culminating in the facilitation of IL-6/leptin-driven Th17 cellular formation and subsequent insulin resistance within adipose frameworks (89). The gene discussed is IL6; the disease is Insulin resistance.